Lilian Schwarz
Prof Lilian Schwarz is an expert in Surgery at Hôpital Charles-Nicolle (France) (France). Lilian Schwarz has authored 187 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 8 of them ongoing. SLR score: 777 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Oncology - Gastroenterology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2026
Number : 187
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Prioritising Psychological Prehabilitation Interventions for Cancer Surgery: An International Delphi Study. PMID 42687322 — surgical oncology, surgical procedures, operative, neoplasms, gastrointestinal neoplasms, therapeutics, psychosocial intervention | ANZ J Surg | 2026 | 0 |
| Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery: A Randomized Clinical Trial. PMID 42616512 — methylprednisolone, intraabdominal infections, surgical procedures, operative, adrenal cortex hormones, neoplasms, wound infection, infections, postoperative complications | JAMA Surg | 2026 | 1 |
| Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis. PMID 42478167 — carcinoma, hepatocellular, minimally invasive surgical procedures, liver, drug-related side effects and adverse reactions, radiofrequency ablation, transplantation | Liver Int | 2026 | 2 |
| Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort. PMID 42414185 — liver diseases, mortality, blood, operative time, morbidity, pancreatectomy | HPB (Oxford) | 2026 | 0 |
| Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National Cohort. PMID 42237086 — mortality, minimally invasive surgical procedures, reoperation, general surgery, pancreatectomy | Ann Surg | 2026 | 0 |
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
8 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| metastatic colorectal cancer 2023-504831-42-00 — neoplasms, drug therapy, liver, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy | Phase 3 | Recruiting | 2025 |
| Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy NCT07547033 — surgical oncology, pancreaticoduodenectomy, neoplasms, adenocarcinoma, mesenteric artery, superior, arteries, pancreas, mesenteric arteries, gestures, dissection, surgeons, head | N/A | Not yet recruiting | 2026 |
| Risk adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 PRODIGE93 PANACHE02 Trial 2024-519048-33-00 — adenocarcinoma, drug therapy, chemotherapy, adjuvant, therapeutics, chemotherapy | Phase 2/Phase 3 | Recruiting | 2025 |
| Risk adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX NCT07044453 — paclitaxel, neoplasms, adenocarcinoma, drug therapy, chemotherapy, adjuvant, chemotherapy | Phase 2/Phase 3 | Recruiting | 2025 |
| Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma Candidate for Participation in the PANACHE02 Clinical Trial NCT07034703 — blood, carcinoma, ductal, adenocarcinoma, biopsy, drug therapy, biomarkers, pancreatic ducts, diagnosis, therapeutics, tissues, chemotherapy, carcinoma | N/A | Not yet recruiting | 2025 |
LeadR Networks
Main global connection map